Cancer

Showing NaN - NaN of 57

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Cancer, Breast Cancer Trial in Worldwide (Ixabepilone + Capecitabine, Capecitabine)

Completed
  • Cancer
  • Breast Cancer
  • Tucson, Arizona
  • +188 more
Oct 6, 2020

Cancer, Breast Cancer, NSCLC Trial in United States (ABBV-075, Venetoclax)

Completed
  • Cancer
  • +7 more
  • Scottsdale, Arizona
  • +9 more
Nov 27, 2019

Cancer Trial in United States (LYC-55716)

Completed
  • Cancer
  • Huntsville, Alabama
  • +19 more
Sep 24, 2019

Cancer Trial in Canada, United States (Lapatinib, Trastuzumab)

Terminated
  • Cancer
  • Chandler, Arizona
  • +115 more
Jun 5, 2019

Cancer Trial in Worldwide (GSK2118436, GSK1120212, Other approved anti-cancer agent)

Completed
  • Cancer
  • Goodyear, Arizona
  • +43 more
Mar 20, 2019

Cancer, Carcinoma, Castrate-Resistant Prostate Cancer Trial in Worldwide (Denosumab)

Completed
  • Cancer
  • +4 more
  • Huntsville, Alabama
  • +73 more
Oct 17, 2018

Cancer Trial in United States (MEDI-575)

Completed
  • Cancer
  • Denver, Colorado
  • +4 more
Apr 3, 2018

Cancer Trial in Dallas, Houston (perifosine)

Completed
  • Cancer
  • Dallas, Texas
  • +1 more
Mar 12, 2018

Cancer Trial in Australia, United Kingdom, United States (Dabrafenib 150 mg twice a day (BID), Rabeprazole 40 mg once daily

Completed
  • Cancer
  • Dabrafenib 150 mg twice a day (BID)
  • +2 more
  • Goodyear, Arizona
  • +5 more
Nov 10, 2017

Cancer Trial in Worldwide (Trametinib (GSK1120212), Docetaxel, Erlotinib)

Completed
  • Cancer
  • Trametinib (GSK1120212)
  • +6 more
  • Scottsdale, Arizona
  • +19 more
Nov 8, 2017

Cancer Trial in United States (GSK1120212, GSK2141795)

Completed
  • Cancer
  • Aurora, Colorado
  • +9 more
Nov 8, 2017

Cancer, Cataract, Low Bone Mineral Density Trial in Worldwide (Denosumab, Placebo)

Completed
  • Cancer
  • +5 more
  • Denosumab
  • Placebo
  • Anaheim, California
  • +171 more
Apr 19, 2017

Cancer Trial in Santa Monica, Boston, Dallas (ARQ 171)

Terminated
  • Cancer
  • ARQ 171
  • Santa Monica, California
  • +2 more
Mar 2, 2017

Tumors, Tumors, Cancer Trial in United States (LB-100 for Injection, Docetaxel)

Completed
  • Tumors
  • +2 more
  • Duarte, California
  • +4 more
Jan 23, 2017

Cancer Trial in United States (Custirsen, paclitaxel and carboplatin)

Completed
  • Cancer
  • Custirsen, paclitaxel and carboplatin
  • Detroit, Michigan
  • +3 more
Oct 7, 2016

Cancer Trial in United States (CGC-11047 and gemcitabine, CGC-11047 and docetaxel, CGC-11047 and bevacizumab)

Completed
  • Cancer
  • CGC-11047 and gemcitabine
  • +6 more
  • Denver, Colorado
  • +11 more
Jun 21, 2016

Cancer Trial in United States (Birinapant)

Completed
  • Cancer
  • Fort Lauderdale, Florida
  • +6 more
Apr 21, 2016

Melanoma, Cancer Trial in Canada, United States (ALVAC(2) Melanoma multi-antigen therapeutic vaccine, Intron A, Interferon alpha

Terminated
  • Melanoma
  • Cancer
  • ALVAC(2) Melanoma multi-antigen therapeutic vaccine
  • Intron A, Interferon alpha -2b
  • Tucson, Arizona
  • +18 more
Apr 12, 2016

Cancer Trial in Ann Arbor, Dallas (Combined nursing invention)

Completed
  • Cancer
  • Combined nursing invention
  • Ann Arbor, Michigan
  • +1 more
Apr 6, 2015

Solid Tumors, Cancer Trial in Worldwide (XL184, Placebo)

Completed
  • Solid Tumors
  • Cancer
  • Scottsdale, Arizona
  • +46 more
Feb 18, 2015

Cancer, Pain Trial in Canada, India, United States (Fentanyl sublingual spray)

Completed
  • Cancer
  • Pain
  • Fentanyl sublingual spray
  • Huntsville, Alabama
  • +51 more
Aug 6, 2013

Cancer Trial in Canada, United States (mycophenolate mofetil, )

Terminated
  • Cancer
  • mycophenolate mofetil
  • placebo
  • Duarte, California
  • +15 more
May 1, 2013

Cancer Trial in Dallas (ARQ 501)

Completed
  • Cancer
  • ARQ 501
  • Dallas, Texas
    Mary Crowley Medical Research Center
Feb 22, 2013

Cancer, Lymphoma Trial in Spain, United States (XL147 (SAR245408))

Completed
  • Cancer
  • Lymphoma
  • XL147 (SAR245408)
  • Augusta, Georgia
  • +3 more
Jan 31, 2013